EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML

NCT02533115 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jazz Pharmaceuticals